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A B S T R A C T
Intensive cancer treatment followed by hematopoietic stem cell transplantation (HCT) results in moderate
to severe fatigue and physical inactivity, leading to diminished functional ability. The purpose of this study
was to determine the eﬃcacy of an exercise intervention, strength training to enhance early recovery (STEER),
on physical activity, fatigue, muscle strength, functional ability, and quality of life after HCT. This single-
blind, randomized clinical trial compared strength training (n = 33) to usual care plus attention control with
health education (UC + AC with HE) (n = 34). Subjects were stratiﬁed by type of transplantation and age. STEER
consisted of a comprehensive program of progressive resistance introduced during hospitalization and con-
tinued for 6 weeks after hospital discharge. Fatigue, physical activity, muscle strength, functional ability, and
quality of life were assessed before HCT hospital admission and after intervention completion. Data were ana-
lyzed using split-plot analysis of variance. Signiﬁcant time × group interactions effects were noted for fatigue
(P = .04). The STEER group reported improvement in fatigue from baseline to after intervention whereas the
UC + AC with HE group reported worsened fatigue from baseline to after intervention. Time (P < .001) and
group effects (P = .05) were observed for physical activity. Physical activity declined from baseline to 6 weeks
after hospitalization. The STEER group was more physically active. Functional ability tests (timed stair climb
and timed up and go) resulted in a signiﬁcant interaction effect (P = .03 and P = .05, respectively). Subjects in
the UC + AC with HE group were signiﬁcantly slower on both tests baseline to after intervention, whereas
the STEER group’s time remained stable. The STEER group completed both tests faster than the UC + AC with
HE group after intervention. Study ﬁndings support the use of STEER after intensive cancer treatment and
HCT. Strength training demonstrated positive effects on fatigue, physical activity, muscle strength, and func-
tional ability. The exact recovery patterns between groups and over time varied; the STEER group either improved
or maintained their status from baseline to after intervention (6 weeks after hospital discharge) whereas the
health education group generally declined over time or did not change.
© 2017 American Society for Blood and Marrow Transplantation.
INTRODUCTION
Intensive cancer treatment followed by hematopoietic stem
cell transplantation (HCT) is considered curative for a number
of hematological malignancies [1] but it is associated with
high 100-day treatment-related mortality [1] and devastat-
ing complications [2,3]. These complications result in highly
distressing symptoms, signiﬁcantly impaired functional status,
and diminished quality of life (QOL) that can last for years
after treatment [4-7]. A marked reduction in physical activ-
ity after intensive cancer treatment and HCT has been
documented [8]. Up to 90% of HCT recipients report severe
persistent fatigue [9-12]. Although the relationship between
physical activity and fatigue is not completely understood,
sustained physical inactivity after HCT is suﬃcient to cause
loss of muscle mass with resulting decreases in strength.
Muscle mass losses during the ﬁrst 6 months after HCT are
frequently not regained even 5 years after transplantation
[13-15].
This clinical picture of impaired recovery after intensive
cancer treatment and HCT closely resembles the clinical syn-
drome of frailty in older adults. Using Fried’s Clinical
Phenotype of Frailty in Older Adults [16] as a guide and
adapted for HCT, we hypothesized that muscle strength plays
a crucial role in preventing the development of physical
deconditioning/frailty and eventual progression to disabili-
ty in HCT recipients (Figure 1). The working hypothesis is that
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muscle strength is needed to break the negative cycle of phys-
ical deconditioning/frailty that beginswith loss of musclemass
leading to decreased strength→ reduced physical activity→
fatigue→ decreased functional ability→ even further loss of
muscle mass. Without intervention, frailty and long-term dis-
ability ensue even though the HCT survivors are free of cancer
[17]. Thus, there is a tremendous need to break this nega-
tive cycle and develop effective interventions to reduce loss
of muscle mass and enhance early recovery.
This study focuses on strength training to enhance early
recovery (STEER) after intensive cancer treatment and HCT.
Exercise is widely promoted as a means for improving phys-
ical functioning in people with cancer [18,19]. Strength
training, in comparison to all other exercise modalities, most
effectively buildsmusclemass [20]; however, few studies have
evaluated strength training in the HCT population. Most HCT
studies combined strength training with aerobic exercises
[21-27], making it diﬃcult to disentangle the individual effects
of strength training. Only 1 small HCT study, besides our pilot
work, employed single-modality strength training [28]. Al-
though beneﬁcial effects were demonstrated, fatigue, physical
activity, and functional ability were not assessed. Our pilot
studies demonstrated that (1) strength training using elastic
resistance bands has potential positive effects on physical ac-
tivity, fatigue, and QOL; and, (2) strength training is feasible
during the early recovery period if the intervention is tai-
lored to the individual’s capabilities, making subject burden
reasonable [29,30].
A strength training intervention to block or reverse phys-
ical deconditioning after HCT is vitally important for
maintaining physical independence, as demonstrated by the
ability to perform everyday activities. From a cost and subject
burden perspective, it is imperative that the independent
effects of strength training be established in this challeng-
ing population. Furthermore, strength training after HCTmay
be more important than aerobic exercise, according to the
American College of Sports Medicine [31]. Given the impor-
tance of maintaining muscle mass and reducing the
debilitating effects of intensive cancer treatment and HCT,
there is a clear need for a randomized clinical trial (RCT) to
evaluate a strength training intervention in the early recov-
ery period after HCT. The purpose of this single-blind RCT was
to compare STEER to usual care plus attention control with
health education (UC + AC with HE) after intensive cancer
treatment and HCT on physical activity, fatigue, muscle
strength, functional ability, and QOL. This study addresses the
following question, “Does strength training enhance recov-




This study employed a single-blind RCT to test the eﬃcacy of the STEER
invention compared with UC + AC with HE after HCT. Subjects were strati-
ﬁed by type of transplantation (allogeneic or autologous) and by age (≤60
years of age or > 60 years of age). Random allocation to treatment and al-
location concealment were achieved using sequentially numbered, opaque,
sealed envelopes [32].
STEER consisted of a comprehensive program of progressive resistance
using elastic resistance bands to strengthen the upper body, lower body, and
abdominal muscles. UC + AC with HE consisted of a standardized health ed-
ucation program. Both study arms contained an in-hospital component
followed by a 6-week post–hospital discharge phase (described in detail
below). Dependent variables included physical activity, fatigue, muscle
strength, functional ability, and QOL. Variables were measured before ad-
mission to the hospital for the HCT to provide baseline information and during
the seventh week after hospital discharge to provide information regard-
ing the eﬃcacy of the intervention and recovery after HCT. The study was
approved by the institutional review board.
Sample and Setting
Consecutively eligible patients 18 years of age or older scheduled to
undergo HCT at a Midwestern academic medical center were invited to par-
ticipate. Patients who were initially eligible for inclusion were scheduled
to undergo HCT for an underlying malignancy and cognitively able to un-
derstand the purpose of the research. Patients contemplating HCT undergo
an extensive medical work-up before transplantation. All of the pretesting
procedures are standard of care and were not considered part of the re-
search. Themedical work-up generally includes a history and physical; multi-
gated acquisition scans to assess heart function; spirometry to assess
pulmonary function; various blood tests to assess kidney, liver, and blood
cell function and exposure to viruses; chest x-rays; urinalysis; and a dental
exam. The treating physicians reviewed all the pretests and provided ap-
proval for subjects to participate in this study. Subjects were excluded if they
presented with a signiﬁcant comorbidity, such as impending pathological
fracture, that would be make it potentially unsafe to exercise if random-
ized to STEER. To continue to participate in the study after hospital discharge,
subjects were required to be ambulatory.
Enrollment was open fromMay 2013 through August 2015. One hundred
eighteen people scheduled for HCT were eligible to participate. Eighty-
four (71%) agreed to participate. Multiple reasons for declining to participate
Figure 1. Model of frailty/physical decondition (adapted from Fried’s Clinical Phenotype of Frailty in Older Adults, 2001).
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were provided, including too much on their plate and not interested in par-
ticipating in the study. Five of the 84 subjects who agreed to participate were
withdrawn from the study before completion of any research activities. An
additional 4 subjects were withdrawn from the study after completing base-
line testing. These 9 subjects did not proceed to HCT. Seventy-ﬁve subjects
were randomized (STEER group, n = 37; UC + ACwith HE group, n = 38). Seven
subjects expired before the end of the study and 1 was lost to follow-up
(STEER group, n = 4; and UC + AC with HE group, n = 4). Sixty-seven sub-
jects completed the study; thus, the study retained 89% of the subjects who
initially enrolled and received a transplant. The primary reason for subject
attrition was death and the death was attributable to the underlying medical
condition.
Strength Training Intervention
The strength training intervention, STEER, consisted of a comprehen-
sive program of progressive resistance to strengthen the upper body, lower
body, and abdominal muscles using elastic resistance bands (Therabands,
Hygenic Corp., Akron, OH) and body weight for resistance. Subjects re-
ceived instruction and began active range of motion 2 times per week while
hospitalized for HCT. Moderate-intensity strength training began immedi-
ately after discharge from the hospital. Hospital discharge was chosen as
the time to initiate the moderate intensity training as HCT patients are gen-
erally considered medically stable; thus, it is a common safe point to initiate
the intervention. Training continued 3 times per week for 6 weeks after hos-
pital discharge. The Borg rating of perceived exertion scale, a 20-point scale,
was used to estimate the intensity of the resistance [33]. The moderate-
intensity strength training prescription was based on a rating of somewhat
hard (Borg scale, 13). Instruction and training were conducted by the prin-
cipal investigator or a trained member of the research team.
STEER consisted of 11 preselected exercises with concentric and eccen-
tric muscle contractions as follows: (1) 8 exercises using elastic resistance
bands (chest ﬂy, biceps curl, triceps extension, shoulder shrug, shoulder
upright row, shoulder lateral raise, knee ﬂexion, and knee extension) and
(2) 3 exercises that used body weight as resistance (wall push-ups, squats,
and bed sit-ups). Some subjects were not able to perform all 11 exercises
when the moderate-intensity strength training intervention was initiated
after hospital discharge. As a result, the initial moderate-intensity exercise
prescription required tailoring to the individual’s capabilities. Subjects were
prescribed as many exercises as they could perform, starting with the easiest
exercises and advancing to the most diﬃcult. Subjects provided return dem-
onstrations of the exercises to ensure proper form and reduce the chance
of injury. All subjects rated their strength training program as moderately
hard, regardless of the number of exercises performed, resistance band used,
and/or number of repetitions/sets performed.
The STEER intervention employed a supervised/unsupervised ap-
proach. Subjects were seen once or twice each week during their regularly
scheduled clinic visit to exercise under the supervision of a member of the
research team. These 1-on-1 sessions were conducted in clinic exam rooms.
Changes to the exercise prescription, mostly advancements, were made at
that time, facilitating progression with the exercise prescription. Progres-
sion of the exercise prescription was structured to ﬁrst increase the number
of repetitions, followed by increasing the number of sets from 1 to 2 sets,
and ﬁnally increasing the resistance level of elastic bands. Subjects were en-
couraged to exercise on their own 2 more times during the week for a total
of 3 times per week. Subjects documented completion of each individual
exercise, including information about the number of repetitions and sets,
on preprinted exercise logs. Subjects were queried regarding exercise ad-
herence and tolerance to the exercise prescription during weekly clinic visits.
This clinic/home-based strength training program was chosen for mul-
tiple reasons: (1) reduces the risk of exposure to pathogens that may be
acquired in other public places such as gyms; (2) reduces the burden of trav-
eling to and from a gym or laboratory in patients who may be experiencing
signiﬁcant fatigue; (3) elastic resistance bands are portable and can be easily
used in a clinic or home setting; (4) makes effective use of the time pa-
tients spend waiting in clinic to exercise under supervision; and (5) the
equipment is affordable so the training program can easily be imple-
mented on a larger scale if successful. Studies involving elastic resistance
exercises demonstrate increased strength [34-37], improved function and
decreased disability [38,39], and improved range of motion and ﬂexibility
[40]. Elastic resistance exercises have been used in a variety of popula-
tions, including multiple myeloma patients [22], the elderly [34,35], cardiac
patients [41], and in our own pilot studies with HCT patients [29,30].
UC + AC with HE
The UC + AC with HE intervention was implemented in 2 phases, similar
to the STEER intervention. During hospitalization for HCT, subjects in the
UC + AC with HE group received 2 visits per week, during which they were
given the opportunity to discuss the hospital experience. After hospital dis-
charge, the 6-week health education programwas implemented. The UC + AC
with HE subjects were seen once each week in clinic during scheduled clinic
appointments to deliver the standardized 1-on-1 education intervention. The
intervention was delivered in the clinic exam rooms. Topics included pro-
tecting your health, working with your doctors, dealing with ﬁnances, and
guides for recommended tests and procedures after HCT. Publicly avail-
able patient education materials from the Center for International Blood and
Marrow Transplant Research and National MarrowDonor Programwere used.
Subjects received usual care recommendations regarding rest, physical ac-
tivity, and exercise from their attending HCT physician. Subjects were not
told that they could not exercise.
Instrumentation
Physical activity
Physical activity was objectively measured during waking hours using
a wrist-worn accelerometer (primary aim), the Actical (Philips Respironics,
Bend, OR) and through self-report (Godin leisure-time exercise question-
naire) [42]. The objectively measured physical activity data were analyzed
using the Actical software (Version 3.0). The following criteria were met for
inclusion in the data analysis: (1) at least 10 hours per day of physical ac-
tivity data was provided during waking hours; and, (2) a minimum of 3 days
of data were provided for both data collection periods (baseline and after
intervention). The average physical count per minute is reported.
Accelerometry is a well-established method to assess physical activity.
Intra- and interinstrument reliability were established using a shaker table
under 6 different conditions of various intensity to produce a range of
accelerometry counts [43]. Correlations with the maximal 6-minute walk
(r = .74, P < .001), level of obstructive disease (forced expiratory volume in
ﬁrst second percent predicted, r = .62, P < .001), and dyspnea (Functional Status
and Dyspnea Questionnaire, dyspnea over the past 30 days, r = −.29; P < .05)
provide support for concurrent validity in people with chronic illnesses [44].
Successful use of wrist actigraphy to quantify physical activity has been re-
ported in several recent studies involving people with cancer, including HCT
patients [8,45-47].
The Godin leisure-time exercise questionnaire was used to assess self-
reported physical activity in terms of usual leisure time exercise behaviors
[42]. This brief, self-report, 4-item instrument assesses the frequency of
periods of strenuous, moderate, and light activities greater than 15 minutes
in duration during a typical 7-day period. The instrument was modiﬁed to
include questions regarding average duration [48]. The instrument has es-
tablished test-retest reliability [42]. Large correlations between the
accelerometers and the Godin leisure-time exercise questionnaire provide
support for convergent validity [49,50].
Fatigue
Fatigue was measured with the Chalder fatigue scale [51] and fatigue
subscale of the European Organization for Research and Treatment of Cancer
Quality of Life Questionnaire (EORTC QLQ-C30) (described below) [52]. The
Chalder fatigue scale is a multidimensional, self-report instrument that mea-
sures physical and mental fatigue using a 4-point Likert scale. Higher scores
indicate greater fatigue. The 11-item instrument has excellent psychomet-
ric properties and has been successfully used in hospitalized and community-
dwelling subjects, including those with hematological malignancies [53,54].
Normative mean scores for the overall fatigue score have been reported as
12.2
(SD = 4.0) in the general Norwegian population [55]. The fatigue subscale
of the EORTC QLQ C-30 (3 items) measures physical fatigue using a 4-point
Likert scale. The EORTC QLQ C-30 is described in detail below. The fatigue
subscale has been used extensively in people with cancer and has estab-
lished reliability and validity [56].
Muscle strength
Three tests of musclemass and strengthwere performed: ultrasonicmea-
surement of the cross-sectional area of the rectus femoris, hand grip strength,
and arm curl test.
Rectus femoris cross-sectional area. The rectus femoris cross-sectional area
was measured using the SonoSite M-Turbo ultrasound system (FUJIFILM
SonoSite, Inc., Bothell, WA). To assess rectus femoris cross-sectional area,
subjects were positioned using a standardized procedure (supine with arms
resting comfortably at their sides, pillow behind head, head of bed el-
evated to 20°, and legs relaxed with knees extended) [57]. The distance
between the anterior superior iliac spine and the upper pole of the patella
was measured in centimeters. Using the superior iliac spine as the starting
reference point, the skin was marked with a pen at 75% of this distance on
the dominant leg [58]. This ink line served as a visual aid for the point of
ultrasound measurement. Placing the transducer perpendicular to the skin
along the longitudinal aspect of the thigh at the 75%mark, the rectus femoris
was located. This location was chosen as the most proximal position on the
thigh where the rectus femoris would be visualized in all subjects using the
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linear transducer [59]. Subjects were asked to tense the muscle so that the
rectus femoris was clearly identiﬁed and then relax the muscle com-
pletely. With the rectus femoris relaxed, 6 consecutive 2-dimensional images
were taken. The cross-sectional area of the rectus femoris was obtained
through manual tracing of the muscle borders using the SonoSite M-Turbo
software.
As a proxy measure for muscle strength, ultrasoundmeasurement of the
rectus femoris has been signiﬁcantly correlated with isometric maximum
voluntary contraction in healthy subjects (r = .80, P < .001) and people with
chronic obstructive pulmonary disease (r = .78, p < .001) [60]. Ultrasoundmea-
surement of the quadriceps has been used to successfully document
signiﬁcant declines in rectus femoris muscle mass after 1 week of leg im-
mobilization in people with knee injuries (P < .001), followed by signiﬁcant
increases in muscle mass after rehabilitation (P < .01) [61]. Ultrasound mea-
sures are strongly correlated with the gold standard magnetic resonance
imaging rectus femoris cross-sectional area (rho = .88) [62].
Hand grip strength. Hand grip strength was measured using a Jamar dy-
namometer (TEC, Clifton, NJ). Testing was performed with subjects sitting
with the shoulder adducted and neutrally rotated. The elbow was ﬂexed at
90° with the forearm in a neutral position and the wrist between 0° and
30° with 0° and 15° ulnar deviation, according to recommendations [63].
The results are reported as the mean of the 3 trials for the dominant hand
[64]. Reported test-retest reliability coeﬃcients for hand grip strength were
.91 for men and .94 for women [65]. Hand grip strength was validated as
an indicator of upper extremity strength by strong correlations between hand
grip strength and forearm muscle area (r = .73), upper arm muscle area
(r = .71), and total muscle mass (r = .65) [66-68].
Arm curl test. Upper body strength was measured with the 30-second
arm curl test. Subjects were instructed to complete as many arm curls as
possible in 30 seconds using the dominant arm. Men used an 8-poundweight
and females used a 5-pound weight. The arm curl test has been used as part
of the Senior Fitness Test [69,70]. The 30-second arm curl test has a mod-
erately strong correlation with the chest press and is a valid surrogate for
upper body strength in frail individuals [71].
Functional ability
Four objective functional ability tests were performed: timed stair climb,
the timed up and go test, 15-foot walk time, and 30-second chair-stand test.
Timed stair climb. The timed stair climbwas used as an indicator of lower
body strength [72]. Subjects were timed with a digital stopwatch as they
ascended a ﬂight of 9 steps. Results are reported in seconds to reach the top
of the ﬂight of stairs. The timed stair climb has excellent test-retest relia-
bility (r = .94) [73]. The results for timed stair climbs have been signiﬁcantly
correlated with isokinetic strength measurement of knee ﬂexors and ex-
tensors [74].
Timed up and go test. The timed up and go test was used as a measure
of basic functional mobility [75]. The timed assessment begins with indi-
viduals sitting down in a standard chair, rising, walking 8 feet, turning around
and returning, then sitting down again. The test demonstrates strong re-
liability with intraclass correlations ranging from .93 in healthy adults [76]
to .96 in community dwelling elders [77]. The test discriminates between
those with worse home independence and increased risk for falls provid-
ing support for construct validity [77,78]. The test has been used successfully
in people with cancer [79].
Fifteen-foot walk time. The 15-foot walk time test (4.57 meters) was used
as an indicator of gait speed. Gait speed was determined by the number of
seconds it took to walk 15 feet [80]. Subjects started in a standing position
and were instructed to walk as quickly and safely as possible pass the 15-
foot line, marked clearly with tape. Timing started when the foot ﬁrst passed
the start line and ended when both feet passed the 15-foot line. Subjects
were told that they should only slow down after passing the line. Subjects
were allowed to use assistive devices, such as canes. Four-meter gait speed
has excellent reliability and validity in older adults [81] and thosewith chronic
obstructive pulmonary disease [82]. The 4-meter gait speed is highly cor-
related with incremental shuttle walk and the 10-meter walk test, providing
support for concurrent validity.
Thirty-second chair-stand test. The 30-second chair-stand test was con-
ducted as an indicator of lower body strength. The 30-second chair-stand
test involves recording the number of stands (sitting in a chair to standing
erect) that a subject can complete in 30 seconds. Good stability and relia-
bility have been reported in community-residing older adults, with test-
retest correlations of .84 for men, .92 for women, and no signiﬁcant changes
in scores over a 2-day period [83]. The 30-second chair-stand test was
validated as an indicator of lower body strength with moderate correla-
tions between the chair-stand test and the 1-repetition maximum weight-
adjusted leg-press performance (r = .78 men and .71 women). Chair-stand
performance was able to discriminate between lower-active participants and
higher-active participants (P < .0001), providing support for construct va-
lidity through contrasted groups. The 30-second chair-stand test is included
in the Senior Fitness Test [69,70].
QOL
The EORTC QLQ C-30 was used to measure QOL [52]. The EORTC QLQ-
C30 (version 3.0) is a 30-item tool consisting of (1) 5 functional scales
(physical, role, emotional, cognitive, and social); (2) a global QOL/health status
scale; (3) 3 multi-item symptom scales (fatigue, pain, and nausea and vom-
iting); and (4) a number of single-item questions (dyspnea, appetite loss,
sleep disturbance, constipation, diarrhea, and ﬁnancial impact) [56]. Twenty-
eight items use a 4-point Likert scale. The global QOL/health status scale
employs a 7-point Likert scale, with 1 being very poor and 7 being excel-
lent. Items on the multi-item subscales are averaged and then converted to
a 0-to-100 scale. Higher scores on the 5 functional scales and the global QOL/
health status scale represent higher levels of functioning. Higher scores on
the symptom scales and the single-item questions indicate higher degrees
of symptomatology. The EORTC QLQ-C30 is a well-established and psycho-
metrically sound instrument usedworldwide in clinical trials involving people
with cancer [56]. High internal consistency has been reported for all of the
multi-item subscales, including the global QOL subscale (range, .80 to .94)
[52,84,85].
Data Collection Schedule and Procedures
Before hospitalization for HCT (baseline)
Wrist actigraphs were placed on the patient’s nondominant hand to
measure physical activity. The subjects were instructed to leave the device
in place for the next 5 days. Subjects were instructed to carry on with normal
activities, including bathing and showering, as the Actical is water-resistant.
At the end of the 5-day period, subjects completed the 3 muscle strength
tests, 4 functional ability tests, and the self-report questionnaires. The ques-
tionnaires were administered via interview. The muscle strength and
functional ability tests took approximately 30 minutes to complete and the
questionnaires took approximately 15 minutes.
After Intervention (during the seventh week after hospital discharge)
The procedures for data collection after intervention were the same as
described for baseline.
Data Analysis
All data analyses were performed using SPSS (Version 22, IBM Corp.,
Chicago, IL). Descriptive statistics were calculated for all measures. Inter-
nal consistency estimates (Cronbach’s alpha) were assessed for all multi-
item Likert items (EORTC QLQ-C30). Split plot analysis of variance (2 × 2)
was used to examine the effects of (1) group assignment (STEER compared
to UC + AC with HE); (2) time (baseline [before HCT] and after interven-
tion, during the seventh week after hospital discharge to coincide with
completion of the intervention); and (3) the group × time interaction on phys-
ical activity, fatigue, muscle strength, functional ability and QOL. The expected
data trends were as follows: (1) both groups (STEER and the UC + AC with
HE) would be similar at baseline; (2) the 2 groups would be signiﬁcantly
different after intervention; (3) the STEER group would improve over time
or remain stable; and, (4) the UC + AC with HE would decline over time or
not change.
RESULTS
Demographic and Clinical Characteristics
Table 1 displays the demographic and clinical treatment
information. The data presented represent the 67 study par-
ticipants who were randomly assigned to a group, underwent
HCT, and completed baseline and postintervention testing.
Subjects ranged in age from 19 to 73 (mean, 53.3; SD, 12.2).
The sample was racially diverse, composed of African Ameri-
cans (n = 26, 39%); Caucasians (n = 30, 45%); and Latino,
Hispanic, or Mexican American (n = 10; 15%). More males
(n = 41; 61%) enrolled than females (n = 26; 39%). The ma-
jority weremarried (n = 30; 45%) and completed some college
as their highest level of education (n = 27; 40%). Over 40% re-
ported incomes less than $30,000 annually. All subjects
received HCT for treatment of an underlying malignancy.
Thirty-nine subjects (58%) received an autologous transplant
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(STEER group = 20; UC + AC with HE group = 19). Twenty-
eight subjects received an allogeneic transplant (STEER
group = 13; UC + AC with HE group = 15). There were no dif-
ferences between groups on any of the demographic data or
clinical characteristics. The means and standard deviations
for physical activity, fatigue, muscle strength, and function-
al ability are presented in Table 2 and QOL variables in Table 3.
Compliance with STEER and UC + AC with HE
Subjects assigned to the STEER arm were asked to com-
plete 18 moderate-intensity strength training sessions after
hospitalization (approximately 1 supervised session per week
depending on scheduled clinic visits and 2 unsupervised visits
per week for 6 weeks for a total of 18 sessions). The mean
compliance rate for exercise session completion was 83%.
Seventy-two percent of subjects (n = 24) completed between
80% and 100% of sessions. Only 1 subject failed to complete
any of the exercise sessions after hospital discharge. Three
subjects completed between 40% and 59% of sessions and 5
completed between 60% and 79%. Subjects assigned to the
UC + AC with HE were asked to complete 6 educational ses-
sions (1 session per week for 6 weeks). Themean compliance
rate for the health education sessions was 97%. Ninety-one
percent (n = 31) completed all 6 educational sessions. One sub-
jected completed 3 educational sessions, 1 completed 4, and
1 completed 5.
Physical Activity
Objectively measured physical activity
The main effects of group, F (1, 65) = 3.913, P = .05, and
time, F (1, 65) = 12.210, P = .001, were signiﬁcant. The STEER
group was signiﬁcantly more physically active than the
UC + AC with HE group. Subjects in both groups experi-
enced a signiﬁcant reduction in physical activity baseline
compared with after intervention. The STEER group experi-
enced a 15% reduction in physical activity whereas the UC +AC
with HE group experienced a 25% reduction, resulting in a
10% difference between the 2 groups. The group × time in-
teraction was not signiﬁcant, F (1, 65) = .295.
Self-reported physical activity
The main effects of group, F (1, 65) = .877; time, F (1,




The group × time interaction effect for overall fatigue was
signiﬁcant, F (1, 65) = 4.380, P = .04 (Figure 2). Tests of simple
main effects revealed that the UC + AC with HE reported sig-
niﬁcantly increased overall fatigue from baseline to after
intervention, t (33) = −2.174, P = .04, while the STEER group
reported improvements in fatigue from baseline to after in-
tervention, although this was not signiﬁcant. The main effects
of group, F (1, 65) = .005, and time, F (1, 65) = .355, were not
signiﬁcant.
Mental fatigue
Mental fatigue followed a similar pattern. The group × time
interaction effect for mental fatigue was signiﬁcant, F (1,
65) = 6.524, P = .01, (Figure 2). Tests of simple main effects re-
vealed that the STEER group reported signiﬁcant
improvements in mental fatigue baseline to after interven-
tion, t (32) = 2.131, P = .04, while the UC + ACwith HE reported
increased fatigue from baseline to after intervention al-
though this was not signiﬁcant. The main effects of group, F
(1, 65) = .313; and time, F (1, 65) = .245, formental fatiguewere
not signiﬁcant.
Physical fatigue
The main effects of group, F (1, 65) = .049; time, F (1,
65) = 2.114; and, group × time interaction, F (1, 65) = 1.921,
for physical fatigue were not signiﬁcant.
Fatigue subscale of the EORTC QLQ C-30
The main effects of group, F (1, 65) = .003; time, F (1,
65) = 1.704; and group × time interaction, F (1, 65) = .174, for
Table 1









Age, mean (SD) 51.9 (12.7) 54.6 (11.6) 53.3 (12.2)
Gender, N (%)
Male 20 (61) 21 (62) 41 (61)
Female 13 (39) 13 (38) 26 (39)
Race, N (%)
African American 14 (42) 12 (35) 26 (39)
White 14 (42) 16 (47) 30 (45)
Hispanic 4 (12) 6 (18) 10 (15)
Other 1 (3) 0 1 (1)
Marital status, N (%)
Never married 6 (18) 10 (29) 16 (24)
Married 18 (55) 12 (35) 30 (45)
Divorced 6 (18) 6 (18) 12 (18)
Separated 2 (6) 3 (9) 5 (7)
Widowed 1 (3) 3 (9) 4 (6)
Education level, N (%)
High school or less 11 (33) 11 (33) 22 (33)
Some college 15 (46) 12 (35) 27 (40)
Graduated from college 5 (15) 5 (14) 10 (15)
Graduate education after
college
2 (6) 6 (18) 8 (12)
Annual family income, N (%)
< $30,000 14 (42) 15 (45) 29 (43)
$31,000-$60,000 10 (30) 7 (21) 17 (25)




2 (6) 2 (6) 4 (6)
Acute myelogenous
leukemia
7 (21) 7 (20) 14 (21)
Chronic lymphocytic
leukemia
1 (3) 1 (3) 2 (4)
Chronic myelogenous
leukemia
2 (6) 1 (3) 3 (4)
Hodgkin lymphoma 2 (6) 0 2 (3)
non-Hodgkin lymphoma 5 (15) 3 (9) 8 (12)
Multiple myeloma 12 (36) 16 (47) 28 (42)
Myelodysplastic syndrome 2 (6) 4 (12) 6 (8)
Donor type, N (%)
Autologous 20 (61) 19 (56) 39 (58)
Sibling 4 (31) 6 (40) 10 (36)
Matched unrelated donor 8 (61) 8 (53) 16 (57)




16.7 (4.2) 18.1 (5.5) 17.4 (4.9)
No. (%) of subjects readmitted
to hospital during post-
hospital intervention phase
3 (9%) 8 (23%) 11 (16%)
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the fatigue subscale of the EORTC QLQ C-30 were not
signiﬁcant.
Muscle Strength
Rectus femoris cross-sectional area
The main effects of group, F (1, 65) = 1.213; time, F (1,
65) = 1.639; and group × time interaction, F (1, 65) = .124, for
the rectus femoris cross-sectional area were not signiﬁcant.
Hand grip strength
The main effect of time was signiﬁcant, F (1, 65) = 33.556,
P < .001. Both groups experienced reductions in hand grip
strength from baseline to after intervention. The main effects
of group, F (1, 65) = 1.528, and group × time interaction, F (1,
65) = .581, for hand grip strength were not signiﬁcant.
Arm curls
The main effects of group, F (1, 65) = 2.801; time,
F (1, 65) = .537; and group × time interaction, F (1, 65) = 3.464,
P = .067, for arm curls were not signiﬁcant. The group × time
interaction effect approached signiﬁcance, so tests of simple
effects were performed. The STEER group was able to perform
signiﬁcantly more arm curls compared with the UC + AC with
HE after intervention, t (65) = 3.05971, P = .03.
Functional Ability
Timed stair climb
Themain effects of time, F (1, 65) = 6.643, P = .01, and group
× time interaction, F (1, 65) = 5.014, P = .03, for the timed stair
climb were signiﬁcant (Figure 3). Test of simple main effects
revealed that the UC + AC with HE group’s timed stair climb
was signiﬁcantly slower from baseline to after intervention,
t (33) = −2.644, P = .01, while the STEER group’s time re-
mained stable. Although there was no signiﬁcant difference
between groups at baseline, the STEER groupwas able to climb
the stairs signiﬁcantly faster after the intervention, t
(44) = 2.293, P = .03. The group effect was not signiﬁcant,
F (1, 65) = 3.308.
Table 2












Self-reported physical activity (Godin) NS NS NS
STEER 18.8 (15.9) 28.2 (25.0)
UC + AC with HE 27.6 (40.6) 29.5 (35.1)
Physical activity (average physical activity count per minute) .05 .001 NS
STEER 214 (131) 182 (113)
UC + AC with HE 173 (97) 129 (83)
Fatigue
Overall fatigue (Chalder fatigue scale) NS NS .04
STEER 16.9 (6.1) 16.3 (4.9)
UC + AC with HE 15.8 (4.7) 17.6 (5.9)
Physical fatigue (Chalder fatigue scale) NS NS NS
STEER 11.7 (4.3) 11.7 (3.9)
UC + AC with HE 10.9 (3.5) 12.1 (4.5)
Mental fatigue (Chalder fatigue scale) NS NS .013
STEER 5.2 (2.4) 4.5 (1.9)
UC + AC with HE 4.9 (2.3) 5.4 (2.4)
Fatigue (EORTC QLQ-C30) NS NS NS
STEER 38.7 (28.9) 41.8 (24.9)
UC + AC with HE 37.6 (25.2) 43.5 (26.9)
Muscle strength
Rectus femoris cross-sectional area, cm2 NS NS NS
STEER 2.94 (1.17) 2.89 (1.13)
UC + AC with HE 2.65 (1.15) 2.57 (1.13)
Hand grip strength, kgs) NS < .001 NS
STEER 34.06 (10.74) 31.12 (10.26)
UC + AC with HE 31.37 (10.58) 27.54 (11.07)
Arm curl test (repetitions in 30 seconds) .099 NS .067
STEER 17.46 (6.05) 18.03 (6.01)
UC + AC with HE 16.29 (4.67) 14.97 (5.45)
Functional ability
Timed stair climb, seconds .074 .012 .029
STEER 5.54 (2.81) 5.72 (2.25)
UC + AC with HE 5.56 (1.79) 8.11 (5.63)
Timed up and go test, seconds .05 NS .05
STEER 7.31 (2.16) 7.18 (1.89)
UC + AC with HE 7.86 (1.90) 10.11 (7.28)
Fifteen-foot walk time, seconds .038 .083 .083
STEER 3.28 (1.01) 3.27 (.86)
UC + AC with HE 3.50 (.73) 4.10 (1.92)
Thirty-second chair stand test, cycles in 30 seconds NS NS NS
STEER 13.03 (4.97) 13.03 (5.58)
UC + AC with HE 11.47 (6.37) 10.44 (6.73)
Body weight, kilogram NS NS NS
STEER 83.92 (22.73) 79.12 (22.70)
UC + AC with HE 84.30 (24.54) 79.56 (24.09)
NS indicates nonsigniﬁcant.
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Timed up and go
The main effects of group, F (1, 65) = 4.885, P = .03, and
group × time interaction, F (1, 65) = 3.940, P = .05, for the timed
and up were signiﬁcant (Figure 3). Test of simple main effects
revealed that the UC + AC with HE group was slower from
baseline to after intervention (approached signiﬁcance), t
(33) = −1.921, P = .06, while the STEER group’s time re-
mained stable. After the intervention, the STEER group was
able to complete the timed up and go test faster than the
UC + AC with HE, t (46) = 2.274, P = .03. There was no signif-
icant difference between groups at baseline. The time effect
was not signiﬁcant, F (1, 65) = 3.133.
Fifteen-foot walk time
The main effect of group, F (1, 65) = 4.481, P = .04, was sig-
niﬁcant. The STEER group completed the 15-foot walk time
faster. The main effects of time, F (1, 65) = 3.095, and group
× time interaction, F (1, 65) = 3.108, were not signiﬁcant. The
time and group × time interaction effects approached signif-
icance (P = .08). As a result, test of simple effects were
conducted. The UC +ACwith HE group’s walk timewas slower,
approaching signiﬁcance, from baseline to after interven-
tion, t (33) = −1.921, P = .06. There was no signiﬁcant difference
in walk time for the STEER group baseline to after interven-
tion. At baseline, no signiﬁcant differences between groups
were detected. After the intervention, the STEER group was
signiﬁcantly faster than the UC + AC with HE, t (46) = 2.274,
P = .02.
Thirty-second sit to stand
The main effects of group, F (1, 65) = 2.337; time, F (1,
65) = .946; and group × time interaction, F (1, 65) = .946, for
the 30-second sit to stand were not signiﬁcant.
QOL
Means and standard deviations for the global QOL subscale,
5 functional subscales, 3 symptom subscales, or single items
are displayed in Table 3. None of these resulted in signiﬁ-
cant group, time, or group × time interaction effects.
DISCUSSION
Intensive cancer treatment followed by HCT is potential-
ly curative but associated with substantial short- and long-
term adverse effects. Effective pragmatic interventions during
the early recovery period are urgently needed to alleviate
Table 3
Means (SD) of QOL (EORTC QLQ C-30)
QOL Variable Baseline After Intervention
Global QOL/health
status
STEER 62.1 (22.7) 64.4 (18.2)
UC + AC with HE 61.5 (21.0) 62.5 (24.9)
Functional subscales
Physical
STEER 78.6 (26.2) 79.4 (18.9)
UC + AC with HE 79.2 (18.1) 74.9 (20.2)
Emotional
STEER 71.7 (25.3) 79.3 (23.9)
UC + AC with HE 74.0 (21.2) 74.0 (25.4)
Role
STEER 70.2 (32.2) 74.7 (28.3)
UC + AC with HE 65.7 (31.2) 74.5 (32.4)
Cognitive
STEER 83.3 (21.7) 86.9 (17.6)
UC + AC with HE 84.3 (17.9) 78.9 (22.1)
Social
STEER 67.7 (33.1) 72.2 (31.1)
UC + AC with HE 74.5 (26.7) 70.1 (31.7)
Symptoms subscales
Pain
STEER 26.8 (27.9) 25.3 (31.8)
UC + AC with HE 33.8 (30.3) 34.8 (33.7)
Nausea/vomiting
STEER 8.1 (22.1) 17.7 (29.7)
UC + AC with HE 10.3 (18.4) 10.3 (19.3)
Single items
Appetite loss
STEER 20.2 (31.1) 22.2 (33.0)
UC + AC with HE 20.6 (26.0) 28.4 (35.9)
Constipation
STEER 11.1 (27.2) 8.1 (22.1)
UC + AC with HE 8.8 (17.0) 9.8 (19.3
Dyspnea
STEER 23.2 (35.8) 20.2 (28.8)
UC + AC with HE 18.6 (24.9) 21.6 (25.8)
Diarrhea
STEER 14.1 (28.9) 10.1 (17.6)
UC + AC with HE 11.8 (25.8) 11.8 (27.1)
Financial impact
STEER 39.4 (32.8) 28.3 (36.4)
UC + AC with HE 33.3 (41.0) 29.4 (36.5)
Sleep disturbances
STEER 32.3 (36.8) 37.4 (38.9)
UC + AC with HE 43.1 (35.3) 39.2 (37.1)
Data presented are mean (SD).
Figure 2. Fatigue.
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symptoms, promote functional independence, and improve
QOL. The ﬁndings from this single-blind RCT demonstrate the
beneﬁcial effects of a strength training program after HCT on
physical activity, fatigue, muscle strength, and functional
ability compared with UC + AC with HE. Importantly, these
positive effects were demonstrated while controlling for the
time, attention, and interpersonal communication received
by the STEER group through the use of an appropriate control
group. The ﬁndings provide support for our model that main-
taining muscle mass through strength training effectively
reduces fatigue and maintains and/or improves muscle
strength and functional ability after intensive cancer treat-
ment and HCT. Although the exact recovery patterns between
groups and over time varied, the STEER group either main-
tained or improved their health status from baseline to after
intervention whereas the US + AC with HE group generally
declined over time.
This study, focused solely on strength training during the
acute recovery period, contributes to a growing body of ex-
ercise research after HCT and addresses a known gap in the
literature. To demonstrate the effectiveness of strength train-
ing, we hypothesized that signiﬁcant group × time interactions
would be found. As expected, strength training preferen-
tially improved fatigue and functional ability (timed stair climb
and timed up and go) as demonstrated by the signiﬁcant in-
teractions effects with trends toward improving muscle
strength (arm curls). This provides evidence that a 6-week
moderate-intensity strength training programmay be a viable
option for enhancing early recovery after HCT. The ﬁndings
are novel as only 1 RCT, besides our pilot work, tested single-
modality strength training [28]. The Cunningham study did
not assess fatigue or functional ability and the exercise in-
tervention focused on inpatient strength training (up to day
35 after transplantation).
We expected to ﬁnd signiﬁcant interaction effects for phys-
ical activity, muscle strength (cross-sectional area of the rectus
femoris and hand grip) and QOL. We found the following:
(1) group and time effects for physical activity, (2) time effects
for hand grip strength, and (3) no effects for QOL or changes
in muscle mass as measured by the rectus femoris cross-
sectional area. As expected, the STEER group was more
physically active as demonstrated by the group effect and only
experienced a 15% decline in physical activity after interven-
tion compared with a 25% drop in the control group. A
signiﬁcant interaction effect, however, was not found. There
are several potential reasons for this. First, our strength train-
ing interventionmay not have been strong enough to produce
a signiﬁcant interaction effect. Second, objective physical ac-
tivity may not be captured adequately by wearing devices on
the wrist. Third, the control group may have consciously at-
tempted to increase physical activity levels in the post-
transplantation period as evidenced by their reports of leisure-
time physical activity. The control group reported more
leisure-time physical activity at baseline and after interven-
tion compared with the strength training group. The results
from the objective physical activity assessments, however, in-
dicate that the strength training group was more physically
active. The reasons for the discrepancy between objectively
measured and self-reported physical activity is not clear but
requires further investigation. Importantly, subjects as-
signed to the control group were not told that they could not
exercise as this would have been unethical. Finally, the in-
terventionmay have no effect on physical activity as the main
effect of strength training is to build and/or maintain muscle
strength.
The results for increasing physical activity through exer-
cise in the HCT literature are mixed. Consistent with our
ﬁndings, Knoll et al. reported that a 12-week outpatient ex-
ercise program, incorporating aerobic and strength exercises,
compared with usual care did not result in a group × time
interaction effect for self-reported physical activity [21]. Con-
versely, Jacobsen et al. conducted a large (n = 711) 4-arm study
comparing a self-directed exercise program with a self-
administered stress management program, a self-directed
exercise program plus self-administered stress manage-
ment, and usual care [86]. The exercise intervention was self-
directed after a brief 20-minute introduction to the program.
Those assigned to the exercise group increased their physi-
cal activity (as measured by the leisure score of the Godin
leisure-time exercise questionnaire) 6 months after the in-
tervention but not at day 30, 60, or 100. The reason for the
delayed response is not clear. Although it seems logical that
exercise would lead to increased physical activity, the mixed
results suggest that further research is needed. In addition,
it would be prudent to collect self-reported as well as ob-
jectively measured physical activity given the discrepancies
between the 2 in our study.
HCT recipients represent an understudied group even
though they may be one of the neediest, in terms of physi-
cal deconditioning after cancer treatment. Twometa-analysis
Figure 3. Functional ability.
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evaluating exercise after HCT identiﬁed positive effects across
a range of potential outcomes, such as fatigue, muscle
strength, and QOL [18,19]. These analyses, however, only in-
cluded 8 [18] and 11 [19] RCTs, demonstrating the continued
need for investigation. Furthermore, small sample sizes, het-
erogeneity of exercise interventions, timing differences related
to exercise initiation, among other factors, make it very dif-
ﬁcult to effectively combine results across studies; and,
ultimately identify the pillars of an ideal exercise program
after HCT. An exercise program for people in the acute re-
covery phase may need to be vastly different than that
developed for long-term survivors.
The importance of developing effective and pragmatic ex-
ercise interventions after HCT cannot be overstated to increase
the likelihood of translation into clinical practice, if success-
ful. Our STEER intervention is innovative as it was tested in
a challenging group of patients during a period of complex
and frequently changing health care needs and because it in-
tegrated seamlessly into existing clinical practice settings,
which is unique and patient centered. Implementing an ex-
ercise program into any clinical practice is challenging and
is even more so in this population. STEER was designed to
maximize beneﬁts and minimize burdens in research sub-
jects by taking advantage of common clinical situations after
HCT, such as frequent clinic visits during the ﬁrst 6 weeks
after hospital discharge and downtime in the clinic when
waiting to see health care providers. Using the downtime in
clinic to exercise after hospitalization is an eﬃcient use of
the subject’s time that does not extend clinic visits and may
increase patient satisfaction althoughwe did notmeasure this.
Elastic resistance bands were used instead of free weights as
they are very portable and unlikely to cause harm if dropped.
Self-eﬃcacy to exercise was promoted by providing instruc-
tion and simulating the exercises without bands during
hospitalization. This also helped build rapport with sub-
jects before beginning the moderate-intensity strength
training. The compliancewith themoderate-intensity program
conducted after hospital discharge was high (83%), demon-
strating acceptability of the intervention and effective tailoring
to the subject’s capabilities. In this study, our goal was to a
balance between intensity of the intervention, making it
strong enough to exert an effect on important variables, such
as fatigue and functional ability, yet simple enough for even-
tual scalability.
This study ﬁndings provides direction for multiple avenues
of scholarship. Continuing this line of inquiry, further re-
search is needed, such as testing STEER in larger samples,
across multiple sites and monitoring subjects over longer
periods of time to determine sustainability of effects. Our
study only followed subjects to the end of the 6-week inter-
vention; this is a limitation of our study. In our next study,
we plan to implement the intervention over 12 weeks and
follow subjects for 6 months to determine the longer-term
effects and sustainability of the strength training interven-
tion. The use of different comparison groups may also
inﬂuence study ﬁndings. In this study, we stringently
controlled for the time, attention, and interpersonal com-
munication received by the STEER group. Our control arm
contained a potentially active ingredient, standardized health
education, and this may have confounded our ability to ﬁnd
QOL effects. Compliance in the control arm was very high for
the 6 educational sessions (over 97%), demonstrating accept-
ability. To promote high subject retention in the control group,
as was the case in our study, it may be important that HCT
subjects assigned to the control arm receive an intervention
perceived to be valuable to their health, but this may come
at the expense of ﬁnding signiﬁcant results for important
variables.
CONCLUSION
A moderate-intensity 6-week strength training interven-
tion enhances early recovery after HCT; reducing fatigue while
maintaining and/or improving muscle strength and func-
tion ability. The recovery patterns for the strength training
and UC + AC with HE groups varied. The strength training
group generally improved or stayed the same over time
while the UC + AC with HE group generally declined. Signif-
icant differences between the groups were found after
intervention. The strength training intervention, speciﬁcal-
ly designed tomaximize beneﬁts to subjects whileminimizing
burdens, was integrated seamlessly into existing clinical prac-
tice settings. A balanced approach to developing exercise
interventions is needed for HCT recipients; making it strong
enough to effect outcomes, simple enough tominimize subject
burdens, and relatively straightforward and uncomplicated
to facilitate translation into clinical practice.
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